4.8 Article

Real-time tracking of self-reported symptoms to predict potential COVID-19

Journal

NATURE MEDICINE
Volume 26, Issue 7, Pages 1037-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41591-020-0916-2

Keywords

-

Funding

  1. Zoe Global
  2. Wellcome Trust [212904/Z/18/Z]
  3. Medical Research Council/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY) [MR/M016560/1]
  4. European Union
  5. Chronic Disease Research Foundation
  6. NIHR Clinical Research Facility
  7. Biomedical Research Centre (based at Guy's and St Thomas' NHS Foundation Trust)
  8. King's College London
  9. Medical Research Council AIM HY project grant
  10. National Institute for Health Research Nottingham Biomedical Research Centre
  11. Alzheimer's Society Junior Fellowship [AS-JF-17-011]
  12. Wellcome/EPSRC Centre for Medical Engineering [WT203148/Z/16/Z]
  13. Wellcome Flagship Programme [WT213038/Z/18/Z]
  14. Evergrande COVID-19 Response Fund Award through the Massachusetts Consortium on Pathogen Readiness (MassCPR)
  15. UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare
  16. MRC [MR/M004422/1] Funding Source: UKRI

Ask authors/readers for more resources

A total of 2,618,862 participants reported their potential symptoms of COVID-19 on a smartphone-based app. Among the 18,401 who had undergone a SARS-CoV-2 test, the proportion of participants who reported loss of smell and taste was higher in those with a positive test result (4,668 of 7,178 individuals; 65.03%) than in those with a negative test result (2,436 of 11,223 participants; 21.71%) (odds ratio = 6.74; 95% confidence interval = 6.31-7.21). A model combining symptoms to predict probable infection was applied to the data from all app users who reported symptoms (805,753) and predicted that 140,312 (17.42%) participants are likely to have COVID-19. Analysis of data from a smartphone-based app designed for large-scale tracking of potential COVID-19 symptoms, used by over 2.5 million participants in the United Kingdom and United States, shows that loss of taste and smell sensations is predictive of potential SARS-CoV-2 infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available